NB Renaissance and Ardian to Acquire Majority Stake in Neopharmed Gentili

NB Renaissance won a beauty contest to partner with Ardian and acquire majority ownership of Italian pharmaceutical group Neopharmed Gentili via a 50/50 vehicle, valuing the company at about €1.4–1.5 billion. The Del Bono family (through Mediolanum Farmaceutici) will retain a minority stake while Ardian will sell its existing stake into the vehicle and reinvest alongside NB Renaissance to hold half of the vehicle.